Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The price of Galera Therapeutics Inc (NASDAQ: GRTX) closed at $0.19 in the last session, down -3.93% from day before closing price of $0.19. In other words, the price has decreased by -$3.93 from its previous closing price. On the day, 2.3 million shares were traded. GRTX stock price reached its highest trading level at $0.204 during the session, while it also had its lowest trading level at $0.1838.
Ratios:
We take a closer look at GRTX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.36 and its Current Ratio is at 4.36.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on August 10, 2023, Downgraded its rating to Neutral and sets its target price to $0.50 from $6 previously.
BofA Securities Downgraded its Buy to Underperform on October 19, 2021, whereas the target price for the stock was revised from $17 to $2.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 08 ’24 when Schneid Yair bought 150,000 shares for $0.17 per share. The transaction valued at 25,650 led to the insider holds 8,043,203 shares of the business.
Schneid Yair bought 175,000 shares of GRTX for $30,185 on Feb 07 ’24. The 10% Owner now owns 7,893,203 shares after completing the transaction at $0.17 per share. On Feb 06 ’24, another insider, Schneid Yair, who serves as the 10% Owner of the company, bought 25,000 shares for $0.20 each. As a result, the insider paid 5,025 and bolstered with 7,718,203 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GRTX now has a Market Capitalization of 10116949 and an Enterprise Value of 144158944.
Stock Price History:
The Beta on a monthly basis for GRTX is 2.03, which has changed by -0.94138974 over the last 52 weeks, in comparison to a change of 0.22379243 over the same period for the S&P500. Over the past 52 weeks, GRTX has reached a high of $3.59, while it has fallen to a 52-week low of $0.09. The 50-Day Moving Average of the stock is -6.49%, while the 200-Day Moving Average is calculated to be -48.71%.
Shares Statistics:
According to the various share statistics, GRTX traded on average about 2.06M shares per day over the past 3-months and 883320 shares per day over the past 10 days. A total of 54.39M shares are outstanding, with a floating share count of 37.99M. Insiders hold about 25.03% of the company’s shares, while institutions hold 14.77% stake in the company. Shares short for GRTX as of 1713139200 were 2657537 with a Short Ratio of 1.29, compared to 1710460800 on 2802362. Therefore, it implies a Short% of Shares Outstanding of 2657537 and a Short% of Float of 6.61.
Earnings Estimates
On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$0.58. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
